GlobalData on MSN
Acesion begins patient enrolment in AP31969 Phase II AF study
The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.
Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering treatments for atrial fibrillation ("AF"), the most common cardiac arrhythmia, today announces enrolment of the first patients ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Implantable ...
May 10, 2005 (New Orleans) – Implantable loop recorders successfully provided a diagnosis in almost half of patients with unexplained syncope or presyncope, New York researchers reported at the Heart ...
Please provide your email address to receive an email when new articles are posted on . Implantable loop recorder screening for atrial fibrillation did not significantly reduce the risk for stroke ...
Dublin, Aug. 26, 2020 (GLOBE NEWSWIRE) -- The "Global Implantable Loop Recorders Market By Application (Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope), By End User (Hospitals, Cardiac ...
Doctors at Columbus Community Hospital now have a high-tech new tool that can help them diagnose irregular heart rhythms that may not show up during standard testing. The tool, called a cardiac loop ...
Please provide your email address to receive an email when new articles are posted on . An artificial intelligence-based ECG analysis solution reduced the rate of false-positive atrial fibrillation ...
Barcelona, Spain, 1 September 2009: The REVISE Study (Reveal in the Investigation of Syncope and Epilepsy) found that 1 in 8 adult patients in the United Kingdom, previously thought to be suffering ...
DUBLIN--(BUSINESS WIRE)--The "Global Implantable Loop Recorders Market By Application (Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope), By End User (Hospitals, Cardiac Centers and Other ...
Bradycardia is a lot more common than generally believed, but is often asymptomatic and not clinically relevant, and may lead to needless pacemaker therapy, suggests a post-hoc analysis of a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results